Tuberculin skin test - Detailed Information

The tuberculin skin test is a delayed hypersensitivity reaction to tuberculin. It indicates infection with a variety of non-tuberculosis mycobacteria, previous infection with M. tuberculosis or BCG vaccination (with the live attenuated mycobacterial strain of M. Bovis).

  • Tuberculosis skin test:

    • It is used as an aid in the diagnosis of tuberculosis (TB) infection.

Tuberculin Dose in Adults

Dosage in Tuberculin skin test:

  • Intradermal: 5 units are given (0.1 mL)

Dosage in TST interpretation:

  • Criteria for positive TST read at 48 to 72 hours :

    • Induration ≥5 mm:

      • Patients with recent close contact with a person with known active TB,
      • HIV infection (or risk factors for HIV infection, but unknown status),
      • patients with chest x-ray consistent with prior TB,
      • patients with organ transplants and
      • immunosuppressed patients receiving prednisone at a dose of 15 mg/day or more  for one month or more
    • Induration ≥10 mm:

      • Patients with clinical conditions that increase the risk of TB infection,
      • IV drug users,
      • mycobacteriology laboratory workers,
      • recent immigrants (ie, ≤5 years) from high-prevalence countries residents and employees of high-risk congregate settings,
      • children <4 years of age, or
      • infants, children, and adolescents exposed to adults at high risk
    • Induration ≥15 mm:

      • Patients who do not fit in any of the above criteria (no risk factors for TB)
      •  A two-step test is recommended when testing will be done at regular intervals (eg, for health care workers).
      • If the first test is negative, a second TST should be done 1 to 3 weeks after the first test was read.

  • TST interpretation  in a health care setting (CDC 2005):

    • Baseline test:

      • ≥10 mm is considered positive (either first or second step)
      • 0 to 9 mm is considered negative
    • Serial testing without known exposure:

      • Increase of ≥10 mm is considered positive
    • Known exposure:

      • ≥5 mm is considered positive in patients with a baseline of 0 mm
      • ≥10 mm is considered positive in patients with negative baseline or previous screening result of >0 mm

Tuberculin Dose in Childrens

Tuberculin skin test:

  • Infants ≥6 months, Children, and Adolescents:
    • Use adult dosing.

Pregnancy Risk Factor: C

  • Studies on animal reproduction have not been done.
  • It is not contraindicated to test during pregnancy.

Breastfeeding: Tuberculin skin test

  • It is unknown if tuberculin purified proteins derivative (PPD), is present in breast milk.
  • Manufacturer advises caution when administering tuberculin testing to nursing mothers.

Tuberculin Dose in Renal Disease:

There are no dosage adjustments given in the manufacturer's labeling.

Tuberculin Dose in Liver Disease:

 There are no dosage adjustments given in the manufacturer's labeling. 

Rare side effects:

  • Cardiovascular:

    • Presyncope
    • Syncope
  • Dermatologic:

    • Erythematous Rash
    • Localized Erythema
    • Localized Vesiculation
    • Rash At Injection Site
    • Skin Rash
    • Skin Ulceration At Injection Site
    • Urticaria At Injection Site
  • Hypersensitivity:

    • Anaphylactoid Reaction
    • Anaphylaxis
    • Angioedema
    • Hypersensitivity Reaction
  • Local:

    • Injection Site Reactions
    • Discomfort At Injection Site
    • Hematoma At Injection Site
    • Injection Site Scarring
    • Local Pruritus
    • Localized Edema
    • Local Tissue Necrosis
    • Pain At Injection Site
  • Respiratory:

    • Dyspnea
    • Stridor
  • Miscellaneous:

    • Fever

Contraindication to Tuberculin skin test Include:

  • Hypersensitivity to tuberculin purified proteins derivative (PPD) and any part of the formulation
  • Previous severe reactions to tuberculin skin test
  • Active Tuberculosis, history of treatment for M. TB infection, or other disease
  • Eczema or severe burns.

Warnings and precautions

  • Viral infections
    • Major viral infections can delay skin testing.

Tuberculin skin test: Drug Interaction

Risk Factor D (Consider therapy modification)

Vaccines (Live)

May diminish the diagnostic effect of Tuberculin Tests. Management: If a parenteral live vaccine has been recently administered, a scheduled PPD skin test should not be administered for at least 4-6 weeks following the administration of the vaccine. Exceptions: Cholera Vaccine.

Monitoring Parameters:

Monitor for immediate hypersensitivity reactions for about 15 minutes following injection. 

How to perform a Tuberculin Skin Test?

  • For intradermal administration only
  • do not administer IV, IM, or SubQ.
  • Apply to the upper third of the forearm (palm up) ≥2 inches from the elbow, wrist, or other injection sites.
  • If neither arm can be used, then administer to back of the shoulder.
  • Avoid skin that is red or swollen
  • Avoid visible veins.
  • Apply using a 27-gauge needle or finer tuberculin syringe.
  • Should form wheal (6 to 10 mm in diameter) as the liquid is injected which will remain almost 10 minutes.
  • Do not apply pressure or bandage at the injection site.
  • Should wheal does not form, repeat the test immediately at another site, at least 2 inches from the first site and circle the second injection site as an indication that this is the site to be read.
  • Document date and time of injection, the person placing TST, location of the injection site, and a lot number of solutions.
  • Read the Tuberculin skin test at 48 - 72 hours following placement.
  • Test results are documented in millimeters even if classified as negative.
  • Erythema and redness of the skin are not indicative of a positive test result.

Mechanism of action of Tuberculin skin test:

  • Tuberculosis can lead to an individual becoming sensitive to antigenic components from the M. tuberculosis organism.
  • Tuberculins can be found in culture extracts that are used to test tuberculin skin preparations.
  • These culture extracts are intracutaneously injected and cause a classic delayed (cellularly) hypersensitivity reaction.
  • The peak reaction takes place after 24 hours. There is induration secondary to cell infiltration and some vesiculation or necrosis.
  • It indicates infection with a variety of non-tuberculosis mycobacteria, previous infection with M. tuberculosis or BCG vaccination (with the live attenuated mycobacterial strain of M. Bovis).

The onset of action: Delayed hypersensitivity reactions: 5 to 6 hours

Peak effect: 48 to 72 hours

Duration: Reactions subsides after a few days

International Brands of Tuberculin:

  • Aplisol
  • Tubersol

Tuberculin Brands in Pakistan:

Mantoux test PPD skin test 

Recent Posts
La Roche-Posay Anthelios Sunscreen SPF 50: The Ultimate Mineral Face Sunscreen for Daily Use
La Roche-Posay Anthelios Sunscreen SPF 50: The Ultimate Mineral Face Sunscreen for Daily Use
La Roche-Posay Toleriane Double Repair Face Moisturizer with Ceramide & Niacinamide for All Skin Types, Immediate Comfort & Long Lasting Hydration, Fragrance Free
La Roche-Posay Toleriane Double Repair Face Moisturizer with Ceramide & Niacinamide for All Skin Types, Immediate Comfort & Long Lasting Hydration, Fragrance Free
Ultra Strength Gas Relief Softgels, Simethicone 180 mg, Antigas
Ultra Strength Gas Relief Softgels, Simethicone 180 mg, Antigas
Effective Remedies for Constipation
Effective Remedies for Constipation

Comments

NO Comments Found